A detailed history of Elo Mutual Pension Insurance CO transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Elo Mutual Pension Insurance CO holds 16,883 shares of BMRN stock, worth $1.19 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,883
Previous 17,119 1.38%
Holding current value
$1.19 Million
Previous $1.5 Million 7.09%
% of portfolio
0.03%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$74.43 - $92.22 $17,565 - $21,763
-236 Reduced 1.38%
16,883 $1.39 Million
Q1 2024

May 13, 2024

BUY
$83.81 - $99.0 $57,828 - $68,310
690 Added 4.2%
17,119 $1.5 Million
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $54,802 - $70,828
719 Added 4.58%
16,429 $1.58 Million
Q3 2023

Nov 14, 2023

BUY
$85.07 - $94.48 $53,083 - $58,955
624 Added 4.14%
15,710 $1.39 Million
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $289,337 - $334,801
3,338 Added 28.41%
15,086 $1.31 Million
Q1 2023

May 12, 2023

SELL
$87.74 - $117.27 $225,491 - $301,383
-2,570 Reduced 17.95%
11,748 $1.14 Million
Q4 2022

Feb 13, 2023

BUY
$80.93 - $108.63 $34,314 - $46,059
424 Added 3.05%
14,318 $1.48 Million
Q3 2022

Nov 10, 2022

SELL
$82.16 - $96.94 $50,281 - $59,327
-612 Reduced 4.22%
13,894 $1.18 Million
Q2 2022

Aug 10, 2022

BUY
$71.48 - $86.85 $4,789 - $5,818
67 Added 0.46%
14,506 $1.2 Million
Q1 2022

May 10, 2022

BUY
$74.28 - $92.69 $41,671 - $51,999
561 Added 4.04%
14,439 $1.11 Million
Q4 2021

Feb 09, 2022

BUY
$71.72 - $91.47 $71,146 - $90,738
992 Added 7.7%
13,878 $1.23 Million
Q2 2021

Aug 13, 2021

SELL
$75.51 - $84.79 $15,932 - $17,890
-211 Reduced 1.61%
12,886 $1.08 Million
Q1 2021

May 12, 2021

BUY
$74.73 - $90.69 $15,170 - $18,410
203 Added 1.57%
13,097 $989,000
Q4 2020

Feb 11, 2021

BUY
$72.61 - $90.2 $936,233 - $1.16 Million
12,894 New
12,894 $1.13 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Elo Mutual Pension Insurance CO Portfolio

Follow Elo Mutual Pension Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elo Mutual Pension Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Elo Mutual Pension Insurance CO with notifications on news.